NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward Life Science Investing
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. Life Science Investing
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Acadia Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference Life Science Investing
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension Life Science Investing
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program Life Science Investing
Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study Life Science Investing
Medtronic Spark Scholarship Launches To Help Students From Low-Income Households Globally Pursue Health Tech Careers Medical Device Investing
Quantum-Si Highlights Significant Development Advancements for Proteus and Industry Leading Technology Pipeline at Investor & Analyst Day Life Science Investing
